Neuroendocrine Tumor — Trials

Neuroendocrine Tumor — Trials · CancerIndex

Clinical trials

Registered studies

805 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 251–288 of 288 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT01658436	BEZ235 Phase II Trial in Patients With Advanced Pancreatic Neuroendocrine Tumors (pNET) After Failure of mTOR Inhibitor Therapy.	completed	Phase 2	31	Novartis PharmaceuticalsINDUSTRY	9	May 2, 2016	clinicaltrials
NCT01628913	Efficacy and Safety of BEZ235 Compared to Everolimus in Patients With Advanced Pancreatic Neuroendocrine Tumors	terminated	Phase 2	62	Novartis PharmaceuticalsINDUSTRY	8	Apr 7, 2016	clinicaltrials